Tuberculosis Drug Discovery: Challenges and New Horizons | Journal of Medicinal Chemistry
Frontiers | Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review
Frontiers | Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine
Microorganisms | Free Full-Text | Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia
Can the GeneXpert MTB/XDR deliver on the promise of expanded, near-patient tuberculosis drug-susceptibility testing? - The Lancet Infectious Diseases
Mycobacterium tuberculosis clinical isolates carry mutational signatures of host immune environments | Science Advances
Summary of HIV-MTB co-infection and treatment scenarios. | Download Table
Phosphoenolpyruvate depletion mediates both growth arrest and drug tolerance of Mycobacterium tuberculosis in hypoxia | PNAS
Xpert MTB/RIF Ultra Is Highly Sensitive for the Diagnosis of Tuberculosis Lymphadenitis in a High-HIV Setting | Journal of Clinical Microbiology
Diagnostic biomarkers for active tuberculosis: progress and challenges | EMBO Molecular Medicine
Figure 3 - Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia - Volume 22, Number 3—March 2016 - Emerging Infectious Diseases journal - CDC
Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test | aidsmap
Cepheid | Cepheid | TB Drug-Resistance Testing | Xpert MTB-XDR
4.2 Adult and adolescent algorithms | MSF Medical Guidelines
The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study | Scientific Reports
Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015–2019 | SpringerLink
Mind the gap – Managing tuberculosis across the disease spectrum - eBioMedicine
Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial | BMC Infectious Diseases | Full Text
New agents for the treatment of drug-resistant Mycobacterium tuberculosis - ScienceDirect
Therapeutic host-directed strategies to improve outcome in tuberculosis | Mucosal Immunology
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis | NEJM
Tuberculosis: Past, present and future of the treatment and drug discovery research - ScienceDirect
Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid | Thorax
